Amgen Inc - Net Worth and Insider Trading
Amgen Inc Net Worth
The estimated net worth of Amgen Inc is at least $4.3 Billion dollars as of 2024-11-29. Amgen Inc is the 10% Owner of BeiGene Ltd and owns about 18,943,802 shares of BeiGene Ltd (BGNE) stock worth over $3.9 Billion. Amgen Inc is also the 10% Owner of Neumora Therapeutics Inc and owns about 35,368,653 shares of Neumora Therapeutics Inc (NMRA) stock worth over $345 Million. Details can be seen in Amgen Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amgen Inc has not made any transactions after 2023-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amgen Inc
Amgen Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amgen Inc owns 7 companies in total, including BeiGene Ltd (BGNE) , Kezar Life Sciences Inc (KZR) , and Unilife Corp (UNISQ) among others .
Click here to see the complete history of Amgen Inc’s form 4 insider trades.
Insider Ownership Summary of Amgen Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BGNE | BeiGene Ltd | 2021-09-10 | 10 percent owner |
| KZR | Kezar Life Sciences Inc | 2018-06-20 | 10 percent owner |
| UNISQ | Unilife Corp | 2016-02-22 | 10 percent owner |
 | | 2013-12-17 | 10 percent owner |
| | 2013-05-30 | 10 percent owner |
| | 2022-01-06 | 10 percent owner |
| | 2023-09-19 | 10 percent owner |
Amgen Inc Latest Holdings Summary
Amgen Inc currently owns a total of 2 stocks. Among these stocks, Amgen Inc owns 18,943,802 shares of BeiGene Ltd (BGNE) as of September 10, 2021, with a value of $3.9 Billion and a weighting of 91.88%. Amgen Inc also owns 35,368,653 shares of Neumora Therapeutics Inc (NMRA) as of September 19, 2023, with a value of $345 Million and a weighting of 8.12%.
Latest Holdings of Amgen Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BGNE | BeiGene Ltd | 2021-09-10 | 18,943,802 | 206.16 | 3,905,454,220 |
| NMRA | Neumora Therapeutics Inc | 2023-09-19 | 35,368,653 | 9.76 | 345,198,053 |
Holding Weightings of Amgen Inc
Amgen Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Amgen Inc has made a total of 1 transactions in BeiGene Ltd (BGNE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in BeiGene Ltd is the acquisition of 165,529 shares on September 10, 2021, which cost Amgen Inc around $50 Million.
According to the SEC Form 4 filings, Amgen Inc has made a total of 1 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neumora Therapeutics Inc is the acquisition of 1,764,705 shares on September 19, 2023, which cost Amgen Inc around $30 Million.
Insider Trading History of Amgen Inc
- 1
Amgen Inc Trading Performance
GuruFocus tracks the stock performance after each of Amgen Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amgen Inc is 3.12%. GuruFocus also compares Amgen Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amgen Inc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amgen Inc's insider trading performs compared to the benchmark.
Performance of Amgen Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.04 | | | | | |
| Relative Return to S&P 500(%) | -4.42 | | | | | |
Amgen Inc Ownership Network
Amgen Inc Owned Company Details
What does BeiGene Ltd do?
Who are the key executives at BeiGene Ltd?
Amgen Inc is the 10 percent owner of BeiGene Ltd. Other key executives at BeiGene Ltd include director & 10 percent owner & Chief Executive Office John Oyler , SVP & General Counsel Chan Henry Lee , and Global Head of R&D Lai Wang .
BeiGene Ltd (BGNE) Insider Trades Summary
Over the past 18 months, Amgen Inc made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 21,808 shares made by Xiaobin Wu , a net sale of 4,186 shares made by Julia Aijun Wang , and a net sale of 11,300 shares made by Lai Wang .
In summary, during the past 3 months, insiders sold 33,070 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 33,070 shares. During the past 18 months, 5,416,337 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,416,337 shares.
BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeiGene Ltd Insider Transactions
Amgen Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Amgen Inc. You might contact Amgen Inc via mailing address: One Amgen Center Drive, Thousand Oaks Ca 91320.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
